Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa.

Kaseje, Neema; Oruenjo, Kennedy; Kaseje, Dan; Evans, Timothy Grant; Tanner, Marcel; Haines, Andy; Nyikal, James

Kaseje, Neema; Oruenjo, Kennedy; Kaseje, Dan; Evans, Timothy Grant; Tanner, Marcel; Haines, Andy; Nyikal, James.

Kaseje N; Surgical Systems Research Group, Kisumu, Kenya nkaseje@gmail.com.
Oruenjo K; Siaya Ministry of Health, Siaya, Kenya.
Kaseje D; Tropical Institute of Community Health and Development, Kisumu, Kenya.
Evans TG; McGill University, Montreal, Quebec, Canada.
Tanner M; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Haines A; London School of Hygiene and Tropical Medicine, London, UK.
Nyikal J; Parliament of the Republic of Kenya, Nairobi, Kenya.

BMJ Glob Health ; 6(5)2021 05.

Article in English | MEDLINE | ID: covidwho-1247365

Subject(s)

COVID-19 Vaccines; COVID-19; Health Resources; Mass Vaccination; Africa/epidemiology; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines/administration & dosage; Health Resources/organization & administration; Humans; Mass Vaccination/organization & administration

Keywords

COVID-19; vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / COVID-19 Vaccines / COVID-19 / Health Resources Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-006289

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google